Company Description

First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases.

First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026.

First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California.

First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.